Cuker, Adam
Lal, Lincy
Roy, Anuja
Elliott, Caitlin
Carlyle, Maureen
Martin, Carolyn
Haenig, Jens
Viana, Ricardo
Funding for this research was provided by:
Novartis Pharmaceuticals Corporation
Article History
Received: 7 December 2021
Accepted: 4 June 2022
First Online: 18 July 2022
Declarations
:
: Adam Cuker served as a consultant for Synergy, has received authorship royalties from UpToDate, and his institution has received research support on his behalf from Alexion, Bayer, Novartis, Novo Nordisk, Pfizer, Sanofi, Spark, and Takeda. Lincy Lal was an employee of Optum, which was paid by Novartis to conduct this study, at the time of the study. Anuja Roy was an employee of Novartis at the time of the study. Caitlin Elliott was an employee of Optum, which was paid by Novartis to conduct this study. Maureen Carlyle is an employee of Optum, which was paid by Novartis to conduct this study. Carolyn Martin is an employee of Optum, which was paid by Novartis to conduct this study. Jens Haenig is a Novartis AG employee and holds shares. Ricardo Viana is a Novartis AG employee and holds shares.